“The findings of our survey indicated that the overall seroprevalence in India was low, with less than one per cent of the adult population exposed to SARS-CoV-2 by mid-May 2020,” the report said.
The survey, conducted between May 11 and June 4, tested blood samples from 28,000 individuals by Covid Kavach ELISA antibody test, warned that the low prevalence observed in most districts indicates that India is in early phase of the pandemic and the majority of the Indian population is still susceptible to SARS-CoV-2 infection.
The report said: “The high infection to case ratio in India could be on account of prioritisation of testing among symptomatic persons or the variability in testing rates across the state.”